Spatial Perturb-Seq: 2026 intact-tissue evidence
Research context
development · conditional · As of 2026-10-10
peer reviewed · 2026-02-21
- Study design
- In-vivo pooled AAV/Cas9 perturbations with barcode-linked spatial transcriptomics in mouse hippocampal tissue.
- Reported result
- Maps perturbation-associated transcriptomic effects within intact tissue architecture.
- Limitations
- Mouse, tissue, delivery and platform-specific findings; neither ligand binding nor clinical therapeutic benefit is directly demonstrated.
Spatial Perturb-Seq combines AAV-delivered genetic perturbation barcodes with spatial transcriptomic readouts in the studied Cas9 mouse hippocampus.
Key knowledge
Spatial Perturb-Seq combines AAV-delivered genetic perturbation barcodes with spatial transcriptomic readouts in the studied Cas9 mouse hippocampus. It relates gene perturbations to sampled cell and neighborhood responses, while candidate intercellular mechanisms need independent tests.
Conditions and scope
- Stereo-seq capture and Xenium targeted imaging have different observable scope; viral tropism, editing efficacy, sampling and animal replication bound inference.
Sources · 1
References
Sources retain their recorded scope. A source link alone does not establish verification of every statement.
Evidence and review
Spatial perturb-seq: single-cell functional genomics within intact tissue architecture: Spatial Perturb-Seq main/results and mouse hippocampal AAV/Cas9 methods (indexed primary full-text passages; assay platform distinctions retained)
2026-10-10 · Bounded author source inspection of spatial perturb-seq: 2026 intact-tissue evidence, including the stated conditions; independent branch review is recorded separately.
Entry details
Permanent link to this entry ↗- Record identity
- res-bio-spatial-perturb-study
- Revision
- research.1
- Structured reference record
- Postgraduate & research reference